Nefedova Y - Search Results

1

Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.

Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D. Yu B, et al. Among authors: nefedova y. Clin Cancer Res. 2003 Jan;9(1):285-94. Clin Cancer Res. 2003. PMID: 12538481

2

Notch signaling is necessary but not sufficient for differentiation of dendritic cells.

Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Cheng P, et al. Among authors: nefedova y. Blood. 2003 Dec 1;102(12):3980-8. doi: 10.1182/blood-2003-04-1034. Epub 2003 Aug 7. Blood. 2003. PMID: 12907456 Free article.

3

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D. Kusmartsev S, et al. Among authors: nefedova y. Cancer Res. 2003 Aug 1;63(15):4441-9. Cancer Res. 2003. PMID: 12907617

4

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.

Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Nefedova Y, et al. Blood. 2004 May 1;103(9):3503-10. doi: 10.1182/blood-2003-07-2340. Epub 2003 Dec 11. Blood. 2004. PMID: 14670925 Free article.

5

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Nefedova Y, et al. J Immunol. 2004 Jan 1;172(1):464-74. doi: 10.4049/jimmunol.172.1.464. J Immunol. 2004. PMID: 14688356

6

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Kusmartsev S, et al. Among authors: nefedova y. J Immunol. 2004 Jan 15;172(2):989-99. doi: 10.4049/jimmunol.172.2.989. J Immunol. 2004. PMID: 14707072

7

Rational design of shepherdin, a novel anticancer agent.

Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC. Plescia J, et al. Among authors: nefedova y. Cancer Cell. 2005 May;7(5):457-68. doi: 10.1016/j.ccr.2005.03.035. Cancer Cell. 2005. PMID: 15894266 Free article.

8

Activation of dendritic cells via inhibition of Jak2/STAT3 signaling.

Nefedova Y, Cheng P, Gilkes D, Blaskovich M, Beg AA, Sebti SM, Gabrilovich DI. Nefedova Y, et al. J Immunol. 2005 Oct 1;175(7):4338-46. doi: 10.4049/jimmunol.175.7.4338. J Immunol. 2005. PMID: 16177074 Free PMC article.

9

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.

Nefedova Y, Nagaraj S, Rosenbauer A, Muro-Cacho C, Sebti SM, Gabrilovich DI. Nefedova Y, et al. Cancer Res. 2005 Oct 15;65(20):9525-35. doi: 10.1158/0008-5472.CAN-05-0529. Cancer Res. 2005. PMID: 16230418 Free PMC article.

10

Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands.

Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Cheng P, et al. Among authors: nefedova y. Blood. 2007 Jan 15;109(2):507-15. doi: 10.1182/blood-2006-05-025601. Epub 2006 Sep 14. Blood. 2007. PMID: 16973960 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters